Found: 5
Select item for more details and to access through your institution.
Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 5, p. 1176, doi. 10.1093/jac/dkae089
- By:
- Publication type:
- Article
Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
- Published in:
- American Journal of Health-System Pharmacy, 2024, v. 81, n. 1, p. e21, doi. 10.1093/ajhp/zxad232
- By:
- Publication type:
- Article
In vitro synergy of the combination of sulbactam-durlobactam and cefepime at clinically relevant concentrations against A. baumannii, P. aeruginosa and Enterobacterales.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 12, p. 2801, doi. 10.1093/jac/dkad244
- By:
- Publication type:
- Article
Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and clinicians.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2242, doi. 10.1093/jac/dkad229
- By:
- Publication type:
- Article
Relative bioavailability of crushed tebipenem administered through a nasogastric tube with and without enteral feeding.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 1, p. 205, doi. 10.1093/jac/dkac375
- By:
- Publication type:
- Article